{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:41:10Z","timestamp":1771602070918,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,5,17]],"date-time":"2015-05-17T00:00:00Z","timestamp":1431820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10815-015-0498-y","type":"journal-article","created":{"date-parts":[[2015,5,16]],"date-time":"2015-05-16T02:04:39Z","timestamp":1431741879000},"page":"1063-1068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and \u201cfreeze-all\u201d: in-depth analysis of genetic predisposition"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2476-7858","authenticated-orcid":false,"given":"Samuel","family":"Santos-Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos P.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Stouffs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Seneca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Tournaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Blockeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,17]]},"reference":[{"issue":"1","key":"498_CR1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","volume":"85","author":"EG Papanikolaou","year":"2006","unstructured":"Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006;85(1):112\u201320. doi: 10.1016\/j.fertnstert.2005.07.1292 .","journal-title":"Fertil Steril"},{"issue":"5","key":"498_CR2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","volume":"73","author":"RS Mathur","year":"2000","unstructured":"Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril. 2000;73(5):901\u20137.","journal-title":"Fertil Steril"},{"issue":"1","key":"498_CR3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"L Engmann","year":"2008","unstructured":"Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril. 2008;89(1):84\u201391. doi: 10.1016\/j.fertnstert.2007.02.002 .","journal-title":"Fertil Steril"},{"issue":"6","key":"498_CR4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.fertnstert.2006.05.049","volume":"86","author":"B Acevedo","year":"2006","unstructured":"Acevedo B, Gomez-Palomares JL, Ricciarelli E, Hernandez ER. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril. 2006;86(6):1682\u20137. doi: 10.1016\/j.fertnstert.2006.05.049 .","journal-title":"Fertil Steril"},{"issue":"1","key":"498_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","volume":"9","author":"A Delvigne","year":"2003","unstructured":"Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003;9(1):77\u201396.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"498_CR6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bpobgyn.2009.02.006","volume":"23","author":"V Vloeberghs","year":"2009","unstructured":"Vloeberghs V, Peeraer K, Pexsters A, D\u2019Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol. 2009;23(5):691\u2013709. doi: 10.1016\/j.bpobgyn.2009.02.006 .","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"498_CR7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","volume":"17","author":"P Humaidan","year":"2011","unstructured":"Humaidan P, Kol S, Papanikolaou EG. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update. 2011;17(4):510\u201324. doi: 10.1093\/humupd\/dmr008 .","journal-title":"Hum Reprod Update"},{"issue":"3","key":"498_CR8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.fertnstert.2011.12.020","volume":"97","author":"L Engmann","year":"2012","unstructured":"Engmann L, Benadiva C. Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support. Fertil Steril. 2012;97(3):531\u20133. doi: 10.1016\/j.fertnstert.2011.12.020 .","journal-title":"Fertil Steril"},{"issue":"3","key":"498_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.fertnstert.2011.12.010","volume":"97","author":"JA Garcia-Velasco","year":"2012","unstructured":"Garcia-Velasco JA. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Fertil Steril. 2012;97(3):527\u20138. doi: 10.1016\/j.fertnstert.2011.12.010 .","journal-title":"Fertil Steril"},{"issue":"2","key":"498_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmi045","volume":"12","author":"G Griesinger","year":"2006","unstructured":"Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update. 2006;12(2):159\u201368. doi: 10.1093\/humupd\/dmi045 .","journal-title":"Hum Reprod Update"},{"issue":"3","key":"498_CR11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.fertnstert.2010.09.040","volume":"95","author":"L Herrero","year":"2011","unstructured":"Herrero L, Pareja S, Losada C, Cobo AC, Pellicer A, Garcia-Velasco JA. Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome. Fertil Steril. 2011;95(3):1137\u201340. doi: 10.1016\/j.fertnstert.2010.09.040 .","journal-title":"Fertil Steril"},{"issue":"9","key":"498_CR12","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/humrep\/det304","volume":"28","author":"S Iliodromiti","year":"2013","unstructured":"Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, et al. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Hum Reprod. 2013;28(9):2529\u201336. doi: 10.1093\/humrep\/det304 .","journal-title":"Hum Reprod"},{"issue":"4","key":"498_CR13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2009.06.001","volume":"19","author":"M Melo","year":"2009","unstructured":"Melo M, Busso CE, Bellver J, Alama P, Garrido N, Meseguer M, et al. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Reprod Biomed Online. 2009;19(4):486\u201392. doi: 10.1016\/j.rbmo.2009.06.001 .","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"498_CR14","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","volume":"26","author":"P Devroey","year":"2011","unstructured":"Devroey P, Polyzos NP, Blockeel C. An OHSS-free clinic by segmentation of IVF treatment. Hum Reprod. 2011;26(10):2593\u20137. doi: 10.1093\/humrep\/der251 .","journal-title":"Hum Reprod"},{"issue":"7","key":"498_CR15","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.fertnstert.2009.08.036","volume":"93","author":"D Bodri","year":"2010","unstructured":"Bodri D, Guill\u00e9n JJ, Trullenque M, Schwenn K, Esteve C, Coll O. Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study. Fertil Steril. 2010;93(7):2418\u201320. doi: 10.1016\/j.fertnstert.2009.08.036 .","journal-title":"Fertil Steril"},{"key":"498_CR16","doi-asserted-by":"crossref","unstructured":"Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a \u201cfreeze-all\u201d strategy: a prospective multicentric study. Fertil Steril. 2011;95(6):2029\u201333. doi: 10.1016\/j.fertnstert.2011.01.163 .","DOI":"10.1016\/j.fertnstert.2011.01.163"},{"issue":"3","key":"498_CR17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.rbmo.2014.05.012","volume":"29","author":"LP Ling","year":"2014","unstructured":"Ling LP, Phoon JW, Lau MS, Chan JK, Viardot-Foucault V, Tan TY, et al. GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at \u2018freeze-all strategy\u2019. Reprod Biomed Online. 2014;29(3):392\u20134. doi: 10.1016\/j.rbmo.2014.05.012 .","journal-title":"Reprod Biomed Online"},{"key":"498_CR18","author":"AS Gurbuz","year":"2014","unstructured":"Gurbuz AS, Gode F, Ozcimen N, Isik AZ. Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases. Reprod Biomed Online. 2014. doi: 10.1016\/j.rbmo.2014.07.022 .","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"498_CR19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","volume":"101","author":"HM Fatemi","year":"2014","unstructured":"Fatemi HM, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, et al. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \u201cfreeze-all\u201d approach in GnRH antagonist protocol. Fertil Steril. 2014;101(4):1008\u201311. doi: 10.1016\/j.fertnstert.2014.01.019 .","journal-title":"Fertil Steril"},{"issue":"6","key":"498_CR20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","volume":"44","author":"A Golan","year":"1989","unstructured":"Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44(6):430\u201340.","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"498_CR21","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.fertnstert.2011.06.057","volume":"96","author":"S Kol","year":"2011","unstructured":"Kol S. A case of severe early-onset OHSS after GnRH-agonist triggering. Fertil Steril. 2011;96(3):e151. doi: 10.1016\/j.fertnstert.2011.06.057 . author reply e152.","journal-title":"Fertil Steril"},{"issue":"2","key":"498_CR22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9378(97)70225-4","volume":"177","author":"SK Abu-Louz","year":"1997","unstructured":"Abu-Louz SK, Ahmed AA, Swan RW. Spontaneous ovarian hyperstimulation syndrome with pregnancy. Am J Obstet Gynecol. 1997;177(2):476\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"498_CR23","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/oxfordjournals.humrep.a019452","volume":"11","author":"A Ayhan","year":"1996","unstructured":"Ayhan A, Tuncer ZS, Aksu AT. Ovarian hyperstimulation syndrome associated with spontaneous pregnancy. Hum Reprod. 1996;11(8):1600\u20131.","journal-title":"Hum Reprod"},{"issue":"10","key":"498_CR24","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/humrep\/12.10.2115","volume":"12","author":"C Carlo Di","year":"1997","unstructured":"Di Carlo C, Bruno P, Cirillo D, Morgera R, Pellicano M, Nappi C. Increased concentrations of renin, aldosterone and Ca125 in a case of spontaneous, recurrent, familial, severe ovarian hyperstimulation syndrome. Hum Reprod. 1997;12(10):2115\u20137.","journal-title":"Hum Reprod"},{"issue":"1","key":"498_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"group E-A-sPcw","year":"2004","unstructured":"group E-A-sPcw. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"6","key":"498_CR26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/humupd\/dmr034","volume":"17","author":"S Altmae","year":"2011","unstructured":"Altmae S, Hovatta O, Stavreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update. 2011;17(6):813\u201328. doi: 10.1093\/humupd\/dmr034 .","journal-title":"Hum Reprod Update"},{"issue":"7","key":"498_CR27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.fpc.0000215073.44589.96","volume":"16","author":"FJ Moron","year":"2006","unstructured":"Moron FJ, de Castro F, Royo JL, Montoro L, Mira E, Saez ME, et al. Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS). Pharmacogenet Genomics. 2006;16(7):485\u201395. doi: 10.1097\/01.fpc.0000215073.44589.96 .","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"498_CR28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1472-6483(10)60041-7","volume":"19","author":"B Rizk","year":"2009","unstructured":"Rizk B. Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome. Reprod Biomed Online. 2009;19(1):14\u201327.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"498_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7827-11-71","volume":"11","author":"TJ O\u2019Brien","year":"2013","unstructured":"O\u2019Brien TJ, Kalmin MM, Harralson AF, Clark AM, Gindoff I, Simmens SJ, et al. Association between the luteinizing hormone\/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation. Reprod Biol Endocrinol RB&E. 2013;11(1):71. doi: 10.1186\/1477-7827-11-71 .","journal-title":"Reprod Biol Endocrinol RB&E"},{"issue":"2","key":"498_CR30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.fertnstert.2007.11.093","volume":"91","author":"SK Achrekar","year":"2009","unstructured":"Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD. Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women. Fertil Steril. 2009;91(2):432\u20139. doi: 10.1016\/j.fertnstert.2007.11.093 .","journal-title":"Fertil Steril"},{"issue":"12","key":"498_CR31","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1210\/jc.2004-1044","volume":"89","author":"C Daelemans","year":"2004","unstructured":"Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, Vassart G, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab. 2004;89(12):6310\u20135. doi: 10.1210\/jc.2004-1044 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"498_CR32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0015-0282(01)03218-6","volume":"77","author":"M Dulitzky","year":"2002","unstructured":"Dulitzky M, Cohen SB, Inbal A, Seidman DS, Soriano D, Lidor A, et al. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertil Steril. 2002;77(3):463\u20137.","journal-title":"Fertil Steril"},{"issue":"1","key":"498_CR33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308\u201311.","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"498_CR34","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812\u20134. doi: 10.1093\/nar\/gkg509 .","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"498_CR35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139. doi: 10.1038\/nmeth0410-248 .","journal-title":"Nat Methods"},{"key":"498_CR36","first-page":"CD001750","volume":"5","author":"HG Al-Inany","year":"2011","unstructured":"Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2011;5:CD001750. doi: 10.1002\/14651858.CD001750.pub3 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"498_CR37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.fertnstert.2011.11.016","volume":"97","author":"P Humaidan","year":"2012","unstructured":"Humaidan P. Agonist trigger: what is the best approach? Agonist trigger and low dose hCG. Fertil Steril. 2012;97(3):529\u201330. doi: 10.1016\/j.fertnstert.2011.11.016 .","journal-title":"Fertil Steril"},{"issue":"5","key":"498_CR38","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/humrep\/dem006","volume":"22","author":"G Griesinger","year":"2007","unstructured":"Griesinger G, von Otte S, Schroer A, Ludwig AK, Diedrich K, Al-Hasani S, et al. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod. 2007;22(5):1348\u201352. doi: 10.1093\/humrep\/dem006 .","journal-title":"Hum Reprod"},{"issue":"9","key":"498_CR39","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/humrep\/det124","volume":"28","author":"A Seyhan","year":"2013","unstructured":"Seyhan A, Ata B, Polat M, Son WY, Yarali H, Dahan MH. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500\u00a0IU hCG. Hum Reprod. 2013;28(9):2522\u20138. doi: 10.1093\/humrep\/det124 .","journal-title":"Hum Reprod"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-015-0498-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-015-0498-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-015-0498-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:21:25Z","timestamp":1559251285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-015-0498-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,17]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1007\/s10815-015-0498-y","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,17]]}}}